Methods of Treating Hair Related Conditions
US-2016338927-A1 · Nov 24, 2016 · US
Methods of treating hair related conditions
US10959970B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10959970-B2 |
| Application number | US-201916515532-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 18, 2019 |
| Priority date | Feb 16, 2009 |
| Publication date | Mar 30, 2021 |
| Grant date | Mar 30, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are methods for treating hair related disorders, including compounds that may be specific or modulate PPAR receptors.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for modulating hair growth in a human subject in need thereof, the method comprising administering to the human subject a therapeutically effective amount of a composition comprising: N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid, or a pharmaceutically acceptable salt; and an excipient. 2. The method of claim 1 , wherein the composition is administered topically. 3. The method of claim 1 , wherein the composition is pharmaceutically and/or cosmetically acceptable. 4. The method of claim 1 , wherein the composition further comprises a hair stimulating agent. 5. The method of claim 1 , wherein the method further comprises administering a hair stimulating agent. 6. A method for treating hair de-pigmentation or vitiligo in a human subject in need thereof, the method comprising administering to the human subject a therapeutically effective amount of a composition comprising: N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid, or a pharmaceutically acceptable salt; and an excipient. 7. The method of claim 6 , wherein the composition is administered topically. 8. The method of claim 6 , wherein the composition is pharmaceutically and/or cosmetically acceptable. 9. The method of claim 6 , wherein the composition further comprises a hair stimulating agent. 10. The method of claim 6 , wherein the method further comprises administering a hair stimulating agent. 11. A method of stimulating hair growth in a human subject in need thereof, the method comprising administering to the human subject a therapeutically effective amount of a composition comprising: N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid, or a pharmaceutically acceptable salt; and an excipient. 12. The method of claim 11 , wherein the composition is administered topically. 13. The method of claim 11 , wherein the composition is pharmaceutically and/or cosmetically acceptable. 14. The method of claim 11 , wherein the composition further comprises a hair stimulating agent. 15. The method of claim 11 , wherein the method further comprises administering a hair stimulating agent.
Assignees
Inventors
Classifications
condensed with carbocyclic rings or ring systems · CPC title
Enzyme modulators, e.g. Enzyme agonists · CPC title
Preparations for care of the hair · CPC title
for countering cellulitis · CPC title
for chemically bleaching or whitening the skin · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10959970B2 cover?
- Disclosed herein are methods for treating hair related disorders, including compounds that may be specific or modulate PPAR receptors.
- Who is the assignee on this patent?
- Nogra Pharma Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K31/196. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).